Image Credit: VectorMine / Shutterstock In a recent review published in the British Journal of Pharmacology , the authors reviewed how glucagon-like peptide 1 receptor (GLP-1) agonists may reduce alcohol and drug-seeking behaviors and evaluated their potential as treatments for addictive disorders
Unlike many peptides that contain one specific amino acid sequence, Cerebrolysin is a mixture of neuropeptides, which is why it is often discussed differently than single peptides such as BPC-157, KPV, or thymosin alpha-1
doi:10.1016/j.exer.2006.10.008
People describe constantly thinking about what they should eat, what they shouldn't eat, what they already ate, what they might eat later, whether they're doing food "right." When people describe experiencing less food noise (or slower digestion) on GLP-1 medications, many call it a relief
Neurol Clin 14:317335 Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinsons disease: Its role in neuronal death and therapeutic implications